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Clinical, pathological and genetic findings of a primary hereditary ataxia found in a 35 
Malinois dog family are described and compared with its human counterpart. Based on 36 
the family history and the phenotype/genotype relationships already described in 37 
humans and dogs, a causal variant was expected to be found in KCNJ10. Rather 38 
surprisingly, whole exome sequencing identified the SLC12A6 39 
c.178_181delinsCATCTCACTCAT (p.(Met60Hisfs*14)) truncating variant. This loss-40 
of-function variant perfectly segregated within the affected Malinois family in an 41 
autosomal recessive way and was not found in 562 additional reference dogs from 18 42 
different breeds, including Malinois. In humans, SLC12A6 variants cause “agenesis of 43 
the corpus callosum with peripheral neuropathy” (ACCPN, alias Andermann 44 
syndrome), due to a dysfunction of this K+-Cl- cotransporter. However, depending on 45 
the variant (including truncating variants), different clinical features are observed within 46 
ACCPN. The variant in dogs encodes the shortest isoform described so far and its 47 
resultant phenotype is quite different from humans, as no signs of peripheral 48 
neuropathy, agenesis of the corpus callosum nor obvious mental retardation have been 49 
observed in dogs. On the other hand, progressive spinocerebellar ataxia, which is the 50 
most important feature of the canine phenotype, hindlimb paresis and myokymia-like 51 
muscle contractions have not been described in humans with ACCPN so far. Since this 52 
is the first report of a naturally occurring disease-causing SLC12A6 variant in a non-53 
human species, the canine model will be highly valuable to better understand the 54 
complex molecular pathophysiology of SLC12A6-related neurological disorders and to 55 
evaluate novel treatment strategies. 56 
Keywords: SLC12A6, KCC3, Andermann syndrome, hereditary ataxia, Malinois dogs, 57 
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causal variant. 58 
INTRODUCTION 59 
It has long been proven that research on human and canine diseases can benefit from 60 
each other because humans and dogs share hundreds of analogous diseases. On the one 61 
hand, existing knowledge typically flows towards canine research, because human 62 
diseases are far more studied than canine diseases. On the other hand, new candidate 63 
genes for complex and/or rare human diseases are easier identified in dogs because they 64 
are often monogenic and common in dog breeds, and the availability of cells or tissues 65 
from a canine model might aid in the characterization of the underlying 66 
pathophysiology especially when appropriate human material is scarce.1 67 
This also applies to hereditary ataxias, a very heterogeneous group of neurological 68 
spinocerebellar disorders characterized by a lack of coordinated muscle movement. 69 
Ataxia can be present as an isolated symptom or as part of a syndrome. In the more than 70 
100 described human hereditary ataxias, similar phenotypes can be caused by variants 71 
in different genes and different variants in the same gene can cause different 72 
phenotypes.2 Described genetic variants, often in genes from conserved pathways, are 73 
repeat expansions, SNVs and INDELs, and follow a dominant, recessive, X-linked or 74 
mitochondrial inheritance. The prevalence of hereditary ataxias in humans varies in 75 
different populations, but ranges between 1-9 in 100 000 (ref. 3). 76 
Ataxia-related phenotypes are also described in several dog breeds, with causal variants 77 
in KCNJ10, GRM1, ITPR1, SNX14, SPTBN2, CAPN1, ATP1B2, RAB24 and SEL1L. 78 
Some of the KCNJ10 variants have been associated with a particular syndrome known 79 
as spinocerebellar ataxia, myokymia, seizures or both (SAMS) in Jack Russel Terriers4 80 
and Malinois5 dogs. Variants in the first 5 genes are also described to cause a 81 
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spinocerebellar ataxia phenotype in humans, a variant in CAPN1 has been reported to 82 
cause spastic paraplegia, but in the last 3 genes no human counterparts have been 83 
identified yet (Supplementary Information File 1). 84 
Here we report a new ataxia-related phenotype of slowly progressive spinocerebellar 85 
ataxia, paraparesis and myokymic-like muscle contractions in a Malinois dog family 86 
caused by a truncating SLC12A6 variant, and compared it with its human counterpart. 87 
MATERIALS AND METHODS 88 
Clinical examination 89 
Four 6-12 month old intact Malinois dogs (3 males and 1 female) from 2 related litters 90 
were presented at the Small Animal Department of the Faculty of Veterinary Medicine 91 
of Ghent University for an uncoordinated gait since the age of 3-6 months. Two 92 
additional affected littermates were seen on video footage and blood was collected from 93 
1 of them. A clinical and neurological examination was performed on all presented 94 
dogs. A complete blood count and serum biochemistry (including glucose and Na+, K+, 95 
Cl-, Ca2+ and Mg2+ electrolytes) was obtained from 5 dogs. Cerebrospinal fluid (CSF) 96 
analysis was performed in 3 dogs. Urinalysis (including electrolyte clearance for Na+, 97 
K+, Cl- and Ca2+) was performed in 2 dogs. Electromyography (EMG) and motor nerve 98 
conduction velocity (MNCV) studies of the sciatic nerves were performed under general 99 
anesthesia in 2 dogs. EMG recordings were made from facial, truncal and appendicular 100 
muscles of the front and hind limbs. Brainstem auditory evoked responses (BAER) was 101 
performed under sedation in 1 dog. Magnetic resonance imaging (MRI; 0.2 Tesla 102 
magnet) of the brain and complete spinal cord was done in 1 dog. A commercially 103 
available electrophysiological unit (Natus Synergy UltraPro, Acertys Healthcare NV, 104 
Aartselaar, Belgium) was used for electrodiagnostic recordings. A summary of the 105 
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clinical investigations performed in each of the 6 affected Malinois dogs (Figure 1) is 106 
shown in Supplementary Information File 2. 107 
Pathological examination 108 
Post-mortem examination was performed in the 4 presented dogs, immediately after 109 
euthanasia. Both central and peripheral nervous tissue samples and skeletal muscle 110 
samples were collected, fixed in 10% neutral buffered formaldehyde, embedded in 111 
paraffin, sectioned at 5 µm and stained with haematoxylin and eosin (H&E). Additional 112 
histochemical stainings on selected sections included luxol fast blue (LFB) and 113 
toluidine blue (TB) on semi-thin sections. Immunohistochemistry (IHC) was performed 114 
for neurofilament (monoclonal mouse anti-human neurofilament protein clone 2F11, 115 
Cat No. M076229-2, Dako, Glostrup, Denmark), synaptophysin (monoclonal mouse 116 
anti-human synaptophysin clone DAK-SYNAP, Cat No. M731501-2, Dako, Glostrup, 117 
Denmark), glial fibrillary acidic protein (polyclonal rabbit anti-glial fibrillary acidic 118 
protein, Cat No. Z033401-2, Dako, Glostrup, Denmark) and ubiquitin (rabbit polyclonal 119 
ubiquitin IHC antibody, Cat No. IHC-00420, Bethyl laboratories, Montgomery TX, 120 
USA). 121 
Genetic analysis 122 
EDTA blood was sampled from 5 affected Malinois and 13 healthy family members 123 
(Figure 1). In addition, EDTA blood was sampled from 118 reference Malinois dogs 124 
and 444 reference dogs from 17 breeds related to Malinois or known to suffer from 125 
ataxia (Supplementary Information File 3). DNA isolation from blood and the structural 126 
variant analysis of KCNJ10 was performed as described in Van Poucke et al5. Details 127 
about the known ataxia-related causal variants in dogs are described in Supplementary 128 
Information File 1. Whole exome sequencing was performed as described in Broeckx et 129 
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al6. The reads were aligned to the reference genome using BWA v0.7.15 (ref. 7). 130 
Duplicate reads were marked with Picard tools v2.1.1. Using the GATK v3.8-0, variants 131 
were called according to the GATK Best Practices.8 From the total list of putative 132 
variants, only those were retained that (1) passed the “hard” quality filter suggested 133 
from the GATK Best Practices, (2) were not found in an internal variant database, nor in 134 
the public database of the online Variant Effect Predictor tool, (3) followed an 135 
autosomal recessive mode of inheritance and (4) were predicted to be nonsynonymous.9-136 
10 Filtering was performed with VCFtools v0.1.14 and custom R-scripts.11 A genotyping 137 
assay for the new variant is described in Supplementary Information File 4. 138 
Cerebrum (unaffected), cerebellum (affected) and cervical spinal cord (affected) tissue 139 
samples were taken from 2 affected dogs. Tissue sampling, RNA isolation and cDNA 140 
synthesis were performed as described by Van Poucke et al12. RT-qPCR assays are 141 
described in Supplementary Information File 5. 142 
RESULTS 143 
Clinical features 144 
Clinical examination was unremarkable in all presented dogs, except for a mild 145 
palmigrade stance. Neurological examination revealed a severe generalized hypermetric 146 
ataxia (worse on the hindlimbs) associated with a mild to moderate degree of 147 
paraparesis and absent patellar reflexes in all dogs (Supplementary Information File 6a). 148 
Generalized (including tongue and eyelids) involuntary vermicular muscle contractions, 149 
strongly resembling myokymia but only triggered by sedation, were also seen in 3 dogs 150 
(Supplementary Information File 6b). 151 
Complete blood count and serum biochemistry were normal. Urinalysis was 152 
unremarkable. EMG was silent in all clinically normal muscles. Unfortunately, EMG 153 
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could not be performed in the muscles with involuntary vermicular contractions as those 154 
were short-lasting and transient. MNCV and BAER did not differ from age-matched 155 
Malinois control dogs. MRI of the brain and whole spinal cord and CSF analysis were 156 
unremarkable. 157 
The ataxia, paraparesis and palmigrade stance of all dogs progressively worsened, 158 
resulting in non-ambulatory paraparesis by 2.5-3 years of age (Supplementary 159 
Information File 6c) and therefore euthanasia was performed. 160 
Pathological features 161 
Weight of the 4 presented dogs ranged from 22 to 26 kg at the time of euthanasia 162 
(weight of healthy littermates at about the same age ranged between 28 and 35 kg). At 163 
necropsy, no gross abnormalities were noted. The histopathologic findings were 164 
consistent with a severe bilateral symmetrical axonopathy of the white matter, 165 
characterized by prominent axonal swelling with vacuolation, affecting the whole spinal 166 
cord, as well as the dorsal and ventral nerve roots, brain stem and cerebellum (in 167 
declining order of severity). Cerebrum, peripheral nerves and skeletal muscles showed 168 
no or rare abnormalities. The lesions showed variation both in degree and in their 169 
location along the spinal cord, as well as within the same animal as in different animals, 170 
but the same pathways were consistently affected in all dogs. The most severe lesions 171 
were noted in some descending motor pathways (prominent in the ventral corticospinal 172 
tract and the vestibulospinal tract and to a lesser extent the lateral corticospinal tract) as 173 
well as in some sensory ascending pathways (prominent in the dorsal spinocerebellar 174 
tract and some mild lesions in the ventral spinocerebellar tract). The lesions consisted of 175 
sharply delineated swollen axons, often appearing optically empty (‘axonal vacuoles’) 176 
yet sometimes filled with a light eosinophilic, amorphous to slightly granular material 177 
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(‘axonal spheroids’). Axonal swelling was often extreme with diameters up to 140 µm. 178 
Neuronal perikarya in the cerebrum, cerebellum, brain stem, spinal cord, and dorsal root 179 
sensory ganglia appeared normal, except for the presence of some slight perikaryal 180 
retraction, probably representing an artefact. LFB stains and semi-thin sections stained 181 
with TB demonstrated well preserved myelin sheaths, both in the central and peripheral 182 
nervous system, surrounding the normal axons, the axonal spheroids and the empty 183 
vacuoles. Only around the extremely dilated axons, the myelin sheath appeared thinned 184 
or could not be visualized. IHC for neurofilament revealed a dilated aspect of almost all 185 
axons in the affected areas and scattered, extremely large axonal spheroids (diameter up 186 
to 140 µm), compatible with the large ‘eosinophilic material filled spheroids’ on H&E. 187 
The latter were also highlighted on IHC for synaptophysin, suggesting this to be 188 
axoplasm of severely dilated axons. No abnormalities were detected in the spinal cord 189 
neuronal cell bodies with synaptophysin or ubiquitin IHC, and no areas of gliosis were 190 
noted on glial fibrillary acidic protein IHC. See Supplementary Information File 7 for 191 
the histopathological lesions on H&E, and on IHC for neurofilament and synaptophysin. 192 
Genetic analysis 193 
Because of the similarities of the syndrome in the dogs of the present study with SAMS 194 
and the fact that SAMS was so far only associated with KCNJ10 variants in dogs, we 195 
first tested the 3 previously described KCNJ10 variants in the affected Malinois dogs. 196 
The c.627C>G4 and c.986T>C5 variants were not present. One dog carried 1 allele of 197 
the g.22141027insC13 variant. Although this variant is not causal in heterozygous state, 198 
we analyzed this variant in the rest of the affected family and in 57 additional reference 199 
Malinois dogs, because it was the first time that this variant was detected in the 200 
Malinois breed. Also the healthy father of the affected Malinois dog and a healthy 201 
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offspring of that father carried 1 allele (Figure 1), and the allele frequency in the 202 
reference Malinois dogs was 4.4%. In addition, we did not find any of the 8 other 203 
described ataxia-related canine variants in the affected Malinois dogs (Supplementary 204 
Information File 1). Next, we followed the candidate gene approach and performed a 205 
structural variant analysis on KCNJ10 in 1 affected Malinois dog. Since no potential 206 
causal variants were found, whole exome sequencing was performed on 4 animals (2 207 
healthy parents and 2 affected siblings; Figure 1). A frameshift inducing INDEL in 208 
SLC12A6 was further investigated as the most likely causal variant after filtering. 209 
SLC12A6 (solute carrier family 12 member 6, alias KCC3; Gene ID: 478239) is located 210 
on canine chromosome 30. Its canonical transcript is encoded in 25 exons and is 211 
translated into a 1151 aa long integral transmembrane protein involved in K+-Cl- 212 
cotransport, predicted to contain 12 transmembrane domains and large hydrophilic 213 
intracellular termini. Alternative transcripts, caused by alternative promoters, alternative 214 
transcript initiation sites, alternative exons (e.g. exon 1a and 1b) and alternative splicing 215 
(e.g. exon 2), give rise to a complex mix of isoforms in many tissue/cell types.14-16 216 
The INDEL involves a 12-bp insertion (CATCTCACTCAT) and a 4-bp deletion 217 
(ATGA), most probably generated by a template switch process with an inverted repeat 218 
and an inverted spacer (Figure 2). The variant is located in exon 1a and causes a 219 
frameshift at codon 60 leading to a premature stopcodon 14 codons downstream in all 220 
transcripts containing exon 1a (Figure 2). The SLC12A6 221 
c.178_181delinsCATCTCACTCAT (p.(Met60Hisfs*14)) variant was deposited in the 222 
EVA database (Project: PRJEB30850; Analyses: ERZ802317). 223 
From the 18 sampled Malinois family members, all 5 affected dogs were homozygous 224 
for the variant allele, 10 healthy dogs carried 1 variant allele and 3 healthy dogs did not 225 
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carry the variant allele, following perfectly an autosomal recessive segregation (Figure 226 
1). The variant was not found in 118 additional reference Malinois dogs, neither in 444 227 
reference dogs from 17 breeds related to Malinois or known to suffer from ataxia 228 
(Supplementary Information File 3). 229 
Because the variant does not affect transcripts containing exon 1b, RT-(q)PCR was 230 
performed, focusing on the first exons, to identify which SLC12A6 transcript variants 231 
(TVs) are transcribed in affected tissues (cerebellum and the cervical spinal cord) 232 
compared to unaffected tissue (cerebrum) from 2 affected Malinois dogs. Sequencing 233 
RT-PCR products identified TVs starting with both exon 1a or 1b, and both with or 234 
without exon 2 (data not shown). To quantify these end-point detection results, we 235 
performed RT-qPCR with specific assays for the 4 observed TVs. Both TVs containing 236 
exon 1a (with or without exon 2) were highly transcribed, while both TVs containing 237 
exon 1b were very weakly transcribed (at least 50 fold less) in all 3 investigated tissues 238 
from both animals (Supplementary Information File 5). 239 
DISCUSSION 240 
SLC12A6 encodes 1 of the 4 distinct K+-Cl- cotransporters that belong to the cation-Cl- 241 
cotransporter family. Their structure, function and regulation are highly conserved 242 
across evolution, and despite their high homology, they exhibit unique patterns of 243 
distribution and fulfill distinct biophysical and physiological roles.16-17 The functional 244 
properties of SLC12A6 are even more complex because it can exist in many isoforms 245 
that can be organized as homo- or hetero-oligomers with other cation-Cl- 246 
cotransporters.18 The SLC12A6 cotransporter is broadly expressed throughout the brain, 247 
spinal cord and peripheral nervous system, amongst other various tissue locations.16,19 It 248 
is inactive under isotonic conditions, but gets activated (by dephosphorylation of its C-249 
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terminus) upon cell swelling where it regulates cell volume by the efflux of K+ and Cl- 250 
ions together with water molecules across the plasma membrane. It is therefore believed 251 
to have a key role in cell volume homeostasis and neuronal activity control.16-18 252 
Naturally occurring disease-causing variants in SLC12A6 are so far only described in 253 
humans, where they cause “agenesis of the corpus callosum with peripheral neuropathy” 254 
(ACCPN, alias Andermann syndrome; phenotype MIM number 218000).20 It is a rare 255 
(prevalence rate of less than 1 in 1 000 000 individuals worldwide)16, multisystemic 256 
disorder, characterized by sensorimotor polyneuropathy, variable degree of agenesis of 257 
the corpus callosum, mental retardation and dysmorphic features.21-22 Psychotic 258 
episodes with visual and auditory hallucinations also have been reported.23 The 259 
histopathologic lesions of ACCPN are a combination of axonal degeneration (axonal 260 
spheroids) with variable myelin swelling or loss (dependent on the location). They are 261 
most pronounced in the peripheral nervous system with progression to axonal loss and 262 
endoneurial and perineurial fibrosis. There is no obvious damage to neurons, no 263 
evidence of active myelin degradation or inflammation. Muscle biopsies show signs of 264 
denervation such as mildly atrophic and angulated fibers.22,24-25 265 
Most causal variants associated with ACCPN are randomly distributed truncating 266 
variants, due to premature stop codons caused by INDEL, nonsense or splice site 267 
variants (recessive; homozygous or compound heterozygous).16-18,20,26 Contrary to what 268 
would be expected, SLC12A6 mRNAs harboring premature termination codons are not 269 
degraded by nonsense-mediated mRNA decay, but are translated as truncated proteins.26 270 
They are associated to loss-of-function because of an aberrant structure or a defective 271 
transit to the plasma membrane.27 Interestingly, Uyanik et al28 described a recessive 272 
missense variant (p.Arg207Cys, modifying a region crucial for oligomerization) 273 
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associated with a milder form of ACCPN, and Kahle et al29 a dominant missense variant 274 
(p.Thr991Ala, abolishing a phosphorylation site crucial for deactivation) associated 275 
with a distinct form of ACCPN due to a gain-of-function. Despite research on human 276 
patients with inherited disease-causing variants or experiments in mouse, Xenopus, 277 
Caenorhabditis and Drosophila model systems, the underlying pathological mechanisms 278 
that account for the neurological manifestations of ACCPN are still not clearly 279 
understood.17-18,30 280 
Here, we describe the first non-human naturally occurring truncating SLC12A6 variant, 281 
segregating in a Malinois dog family descending from a common ancestor, due to an 282 
INDEL in exon 1a, causing a frameshift at codon 60 and resulting in a premature 283 
stopcodon after 13 aberrant codons. It only affects TVs containing exon 1a and encodes 284 
the shortest truncated SLC12A6 protein reported so far, comprising only a part of the 285 
intracellular N-terminus (Figure 2). As such, it can be considered as a loss-of-function 286 
variant. As in ACCPN patients, affected Malinois dog family members are homozygous 287 
for the truncating SLC12A6 variant, and heterozygotes are asymptomatic carriers. 288 
Because the SLC12A6 variant was only found in the affected Malinois family, it is 289 
likely a private variant because of a founder effect. In contrary, the g.22141027insC 290 
variant13 has an estimated frequency of 4.4% in the Belgian Malinois population and 291 
should be taken into account in breeding schemes. 292 
In agreement with what has been seen in humans26, RT-qPCR results show that 293 
SLC12A6 mRNAs harboring a premature termination codon (i.e. TV1 and TV2) are not 294 
degraded by nonsense-mediated mRNA decay in dogs either, and will probably be 295 
translated into truncated proteins as well. The fact that the levels of transcripts 296 
containing exon 1b (i.e. TV3 and TV4) are low (at least 50 times lower than transcripts 297 
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containing exon 1a) and unchanged in affected tissues compared to unaffected tissue, 298 
makes it very unlikely that they can take over the role of the predominant transcripts 299 
containing exon 1a. 300 
Electrophysiological findings associated with ACCPN in humans are abnormal resting 301 
activity on EMG, increased duration of motor unit potentials, increased polyphasia, 302 
decreased MNCV and absent sensory action potentials.21-22 Electrophysiology was 303 
entirely normal in the 2 investigated dogs, and furthermore no signs of sensorimotor 304 
neuropathy were found on histopathology. As EMG confirmation of myokymia could 305 
not be obtained in the muscles with involuntary vermicular contractions, we decided to 306 
refer to those as “myokymic-like muscle contractions”. 307 
Homozygous SLC12A6 global knockout in mice has been reported to reproduce the 308 
typical ACCPN sensorimotor neuropathy, as well as neurogenic hypertension, age-309 
related deafness, renal dysfunction and a reduced threshold to develop epileptic 310 
seizures.31 However, only minor changes of the corpus callosum have been reported in 311 
mice, and a complete agenesis has not yet been described in that species.17 No signs of 312 
corpus callosum abnormalities nor signs of sensorineural deafness were seen in the 313 
investigated dogs. None of them developed epileptic seizures and their normal blood 314 
and urine analysis suggest normal renal function. Phenotypically, the current described 315 
syndrome seems quite similar to the SAMS syndrome previously reported in Malinois 316 
dogs5 and Jack Russell Terriers4,32, both caused by a KCNJ10 variant. Still, some 317 
differences are undeniably present. The age of onset is younger in SAMS (6-8 weeks) 318 
and the progression to non-ambulatory status is also more rapid in SAMS (before 6 319 
months of age) compared to the dogs investigated here (respectively 3-6 months and 320 
2.5-3 years of age). Paraparesis and palmigrade stance were seen in this study but were 321 
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not described in SAMS. Epileptic seizures have also been described in dogs with SAMS 322 
but were not seen here. Myokymia were clearly seen in dogs with SAMS when awake 323 
(confirmed by electrophysiological examination) and even progressed to neuromyotonia 324 
episodes in some cases, while the myokymic-like muscle contractions were only seen 325 
here when the dogs had been sedated and disappeared shortly after the induction of 326 
anesthesia. SAMS dogs also repetitively present some degree of subclinical 327 
sensorineural deafness, which was not seen here when a BAER test was performed.5,32 328 
Those differences might be explained amongst others, by the fact that KCNJ10 encodes 329 
a voltage-gated K+ channel4,5, while SLC12A6 encodes an electroneutral K+-Cl- 330 
cotransporter in the brain and spinal cord. 331 
The marked phenotypic differences between the human and canine phenotype of 332 
SLC12A6 variants are striking, but quite pronounced phenotypic variations have already 333 
been reported between human patients, as well as with mice.17 Interestingly, as in 334 
humans where patients with ACCPN have extremely low body weights and heights25, 335 
affected dogs weighted about 25% less than age-matched littermates at the time of 336 
euthanasia. 337 
The histopathologic findings show a strong correlation with the human ACCPN, as both 338 
display a severe axonopathy with striking unnoted neuronal damage, inflammation or 339 
gliosis. The dogs developed lesions in both central (mainly spinal cord and brain stem) 340 
and peripheral nervous system (mainly nerve roots), broadly consistent with the 341 
localization pattern in humans and mouse.25 An important difference in dogs is the 342 
severe, bilateral symmetrical vacuolation of the spinal cord white matter, a feature not 343 
well described in humans. A large amount of these vacuoles are severely dilated axons, 344 
as IHC for neurofilament and synaptophysin stained positive if axoplasm was still 345 
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present. The slightly different distribution pattern and minor interspecies differences can 346 
be explained by 2 complementary hypotheses. Firstly, most human case reports do not 347 
describe a complete necropsy and histopathology is (only) performed on biopsies of a 348 
peripheral sensory nerve (the sural nerve).24,28,33-34 Auer et al25 did perform a complete 349 
necropsy on 8 human patients and described some mild lesions in the spinal cord with 350 
scattered vacuoles. Secondly, dogs in this case report are all euthanized for humane 351 
reasons at an age of 1 to 3 years, in a disease state where they would not have 352 
spontaneously died. This is in contrast to the human patients with ACCPN who died a 353 
natural death, mostly due to respiratory failure, at a more advanced stage of disease 354 
around 20-30 years old.25 As this is a chronic, progressive disease, an evolution in type 355 
of lesions and distribution pattern can be expected. 356 
We conclude that the loss-of-function SLC12A6 c.178_181delinsCATCTCACTCAT 357 
(p.(Met60Hisfs*14)) truncating variant causes an ataxia-related phenotype of slowly 358 
progressive spinocerebellar ataxia, paraparesis and myokymic-like muscle contractions 359 
in Malinois dogs. Although the SLC12A6 variant in dogs resembles genetically the most 360 
frequently observed variants in humans, the clinical phenotype in dogs is quite different 361 
from ACCPN in humans. Since this is the first report of a naturally occurring disease-362 
causing SLC12A6 variant in a non-human species, the canine model will be highly 363 
valuable to better understand the complex molecular pathophysiology of SLC12A6-364 
related neurological disorders and to evaluate novel treatment strategies. 365 
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TITLES AND LEGENDS TO FIGURES 474 
Figure 1. Pedigree of the affected Malinois family (drawn with the kinship2 package in 475 
RStudio35). Squares represent males, circles females, grey icons non-sampled dogs, 476 
black icons sampled dogs, non-shaded icons healthy dogs, shaded icons affected dogs 477 
and strikethrough icons deceased dogs. Numbers correspond to the investigated dogs 478 
described in Supplementary Information File 2. Dog X was euthanized because of the 479 
same symptoms but no video footage nor blood sample was available to confirm the 480 
diagnosis. Whole exome sequencing was performed on dogs marked with a degree sign. 481 
The SLC12A6 c.178_181delinsCATCTCACTCAT genotype is shown as Wt/Wt, Wt/Mt 482 
or Mt/Mt. Dogs with an asterisk carry 1 allele of the g.22141027insC variant.13 483 
Figure 2. Description, origin, location and influence on protein structure of the 484 
SLC12A6 c.178_181delinsCATCTCACTCAT (p.(Met60Hisfs*14)) variant. The upper 485 
part shows a schematic representation of the genomic structure of the first exons of 486 
SLC12A6. White boxes represent exonic untranslated regions, black boxes exonic 487 
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coding regions and the white vertical bar the position of the SLC12A6 488 
c.178_181delinsCATCTCACTCAT variant. The middle part shows the chromatograms 489 
of the wild type (Wt) and the mutated variant (Mt), and the proposed origin of the 490 
INDEL by a template-switch process (1-3-4-2) with inverted repeat (arrows) and 491 
inverted spacer (dotted line) as described by Löytynoja and Goldman36. The lower part 492 
shows the predicted structure of the canonical SLC12A6 protein (Wt) and the truncated 493 
variant translated from the INDEL-containing transcript (Mt), drawn with Protter37. 494 
SUPPLEMENTARY INFORMATION 495 
Supplementary Information File 1 (*.pdf) 496 
Table showing genotypes of the described canine ataxia-related variants in Malinois 497 
dogs. 498 
Supplementary Information File 2 (*.pdf) 499 
Table showing a summary of the clinical investigations performed in each of the 6 500 
affected Malinois dogs. 501 
Supplementary Information File 3 (*.pdf) 502 
Table showing genotypes of the SLC12A6 c.178_181delinsCATCTCACTCAT variant 503 
in reference dog breed populations. 504 
Supplementary Information File 4 (*.pdf) 505 
Description sheet of the genotyping assay for the SLC12A6 506 
c.178_181delinsCATCTCACTCAT variant. 507 
Supplementary Information File 5 (*.pdf) 508 
Description sheet of the SLC12A6 RT-qPCR assays and results. 509 
Supplementary Information File 6a (*.mpg4) 510 
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Video showing severe generalized hypermetric ataxia (worse on the hindlimbs) 511 
associated with a mild to moderate degree of paraparesis and a mild palmigrade stance 512 
at 12-month of age (dog 3). 513 
Supplementary Information File 6b (*.mpg4) 514 
Video showing short-lasting, transient generalized involuntary vermicular muscle 515 
contractions (myokymia-like muscle contractions) triggered by sedation (dog 3). 516 
Supplementary Information File 6c (*.mpg4) 517 
Video showing the progression of the ataxia and paraparesis resulting in non-518 
ambulatory paraparesis by 3 years of age (dog 3). The palmigrade stance is also notably 519 
worse. 520 
Supplementary Information File 7 (*.pdf) 521 
Figures showing histopathological lesions on haematoxylin and eosin (H&E), and on 522 
immunohistochemistry (IHC) for neurofilament and synaptophysin. 523 
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